Institutional members access full text with Ovid®


Kim, Grace H. M.D.; Mocco, J M.D.; Hahn, David K. B.A.; Kellner, Christopher P. B.A.; Komotar, Ricardo J. M.D.; Ducruet, Andrew F. M.D.; Mack, William J. M.D.; Connolly, E. Sander Jr. M.D.

doi: 10.1227/01.NEU.0000313581.36723.8D
Experimental Studies

OBJECTIVE: The complement cascade has been implicated in cerebral ischemia/reperfusion injury. To develop clinically useful therapies that successfully manipulate the complement cascade, the individual roles of its components must be clearly defined. Previous studies have shown that C5 inhibition improves outcome after experimental stroke. In this study, we investigated the role of C5a in stroke injury by inhibiting its activity at the receptor level.

METHODS: C5a receptor antagonist or vehicle was administered to mice before temporary middle cerebral artery occlusion. Stroke outcomes were assessed 24 hours later in all mice using both neurological deficit scores and cerebral infarct volumes.

RESULTS: Animals treated with C5a receptor antagonist experienced significantly decreased infarct volume and demonstrated an improving trend in neurological function.

CONCLUSION: These findings demonstrate that modulation of C5a receptor activity significantly alters the degree of neurological damage after experimental reperfused stroke.

Department of Neurological Surgery, Columbia University, New York, New York

Reprint requests: Grace Kim, M.D., Columbia College of Physicians and Surgeons, 630 W. 168th Street, Room 5-462, New York, NY 10032. Email:

Received, July 5, 2007.

Accepted, December 17, 2008.

Copyright © by the Congress of Neurological Surgeons